Clinical Trials Directory

Trials / Unknown

UnknownNCT01449253

Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
All India Institute of Medical Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is an open label, randomized, interventional study indented to find the efficacy of different treatment regimens in treatment of pulmonary hypertension secondary to lung disease and/or hypoxia.This is to find out when to start combination therapy (sildenafil plus bosentan) in treatment of pulmonary hypertension secondary to lung disease and/or hypoxia.

Detailed description

This is an open label, randomized, interventional study indented to find the efficacy of different treatment regimens in treatment of pulmonary hypertension secondary to lung disease and/or hypoxia. It involves 3 arms, one getting monotherapy with sildenafil for 6 months, 2nd getting bosentan monotherapy initially for 3 months and then combination of sildenafil and bosentan for 3 months, 3rd getting combination sildenafil and bosentan from the beginning for 6 months. The aim is to decide when is the best time to start combination therapy either from start or at the time of drug failure. Improvement will be assessed by change in functional class, pulmonary pressures measured by ECHO, pulmonary function test, six minute walk test and biochemical markers. Lack of randomized trials and Indian data is there on the subject. Also adverse events and serious adverse events will be closely monitored and reported to the ethics committee and DCGI immediately.

Conditions

Interventions

TypeNameDescription
DRUGSildenafil20 mg initially and then increased to 20 mg TDS if there is no fall in BP
DRUGBosentanBosentan 62.5 mg BD initially for 1 month and then increased to 125 mg BD

Timeline

Start date
2011-08-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2011-10-10
Last updated
2013-01-29

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01449253. Inclusion in this directory is not an endorsement.